首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Performance of urinary NGAL and L-FABP in predicting acute kidney injury and subsequent renal recovery: A cohort study based on major surgeries
【24h】

Performance of urinary NGAL and L-FABP in predicting acute kidney injury and subsequent renal recovery: A cohort study based on major surgeries

机译:尿NGAL和L-FABP在预测急性肾损伤和随后的肾恢复中的性能:一项基于大手术的队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Acute kidney injury (AKI) is a frequent complication of major surgery. The current study evaluated the power of two biomarkers [urinary neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid binding protein (L-FABP)] to detect the occurrence of AKI and to predict the recovery from renal dysfunction in a major surgery cohort. Methods: In this prospective study, 199 patients undergoing major surgery were enrolled. Urinary samples collected from participants before surgery, and 0, 4, and 12 h and 1, 2, 7, and 14 days after surgery were tested for NGAL and L-FABP. Results: Thirty-seven (18.6%) subjects developed AKI. Urinary NGAL and L-FABP were significantly increased from the time surgery was completed (p<0.05). The peak levels of NGAL and L-FABP occurred 12 and 4 h postoperatively (16.4-and 172.0-fold compared to baseline) in AKI group, respectively. The area under the receiver operating characteristic (ROC) curve (AUC) in NGAL (at 12 h), L-FABP (at 4 h), the most predictive model (NGAL at 12 h+L-FABP at 4 h), and the best combination at the same time point (12 h) was 0.83 [95% confidence interval (CI), 0.74-0.91], 0.85 (95% CI 0.77-0.93), 0.94 (95% CI 0.89-0.98), and 0.91 (95% CI 0.85-0.97), respectively. However, the largest AUC of single and combined biomarkers for predicting non-recovery after AKI only reached 0.70. Conclusions: Urinary NGAL and L-FABP can be used to detect AKI and combining NGAL and L-FABP may improve the diagnostic performance; however, NGAL and L-FABP may be poor predictors for renal recovery after AKI.
机译:背景:急性肾损伤(AKI)是大手术的常见并发症。当前的研究评估了两种生物标记物[尿中性粒细胞明胶酶相关的脂钙蛋白(NGAL)和肝型脂肪酸结合蛋白(L-FABP)]的功能,以检测AKI的发生并预测主要患者肾脏功能障碍的恢复手术队列。方法:这项前瞻性研究纳入了199例接受大手术的患者。对从手术前,手术后以及手术后0、4、12 h和1、2、7和14天的参与者收集的尿液样本进行了NGAL和L-FABP测试。结果:37名(18.6%)受试者发生了AKI。手术结束后尿液中的NGAL和L-FABP显着增加(p <0.05)。在AKI组中,NGAL和L-FABP的峰值水平分别在术后12和4小时出现(与基线相比,分别为基线的16.4和172.0倍)。 NGAL(12小时),L-FABP(4小时),预测性最高的模型(12小时的NGAL + 4小时的L-FABP)和接收器工作特性(ROC)曲线(AUC)下的面积,以及在同一时间点(12小时)的最佳组合是0.83 [95%置信区间(CI),0.74-0.91],0.85(95%CI 0.77-0.93),0.94(95%CI 0.89-0.98)和0.91 (95%CI 0.85-0.97)。然而,在AKI仅达到0.70之后,用于预测不可恢复的单一和组合生物标记物的最大AUC。结论:尿NGAL和L-FABP可用于AKI的检测,结合NGAL和L-FABP可提高诊断性能。但是,NGAL和L-FABP可能是AKI后肾恢复的不良预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号